Atreca to Present at Two Upcoming Virtual Investor Conferences
03 September 2020 - 10:00PM
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company
focused on developing novel therapeutics generated through a unique
discovery platform based on interrogation of the active human
immune response, today announced that it will participate in the
following upcoming virtual investor conferences:
H.C. Wainwright & Co. 22nd Annual Global Investment
Conference 2020 Wednesday, September 16, 2020Presentation
time: 3:30 p.m. EDT
Morgan Stanley Virtual Global Healthcare Conference
2020 Thursday, September 17, 2020 Presentation time: 3:30
p.m. EDT
A live audio webcast of each presentation can be accessed
through the Events & Presentations section of the Company's
website at ir.atreca.com. An archived replay of each webcast will
be available on the Company's website for 90 days following the
live presentations.
About Atreca, Inc. Atreca is a
biopharmaceutical company developing novel antibody-based
immunotherapeutics generated by its differentiated discovery
platform. Atreca’s platform allows access to an unexplored
landscape in oncology through the identification of unique
antibody-target pairs generated by the human immune system during
an active immune response against tumors. These antibodies provide
the basis for first-in-class therapeutic candidates, such as our
lead product candidate ATRC-101. A Phase 1b study evaluating
ATRC-101 in multiple solid tumor cancers is currently enrolling
patients. For more information on Atreca, please visit
www.atreca.com.
ContactsAtreca, Inc. Herb Cross Chief Financial
Officer info@atreca.com Investors: Alex Gray,
650-779-9251agray@atreca.com
Media:Sheryl Seapy, 213-262-9390sseapy@w2ogroup.com
Source: Atreca, Inc.
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Apr 2024 to May 2024
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From May 2023 to May 2024